Research fellow

Prof. Dr. Iris Pigeot

Curriculum vitae

Professor Iris Pigeot has been the director of the today’s Leibniz Institute for Prevention Research and Epidemiology - BIPS since March 2004 and has been in charge of the Department of Biometry and Data Management of the institute since September 2001.

Having finished her studies in statistics and sociology at the University of Dortmund in 1985, she worked as a scientific assistant, earned her doctorate with a dissertation on the topic “Estimators of common odds ratios in sparse contingency tables” in 1989, and earned a professorship for statistics with a post-doctoral dissertation entitled “Multiple tests in outlier detection” in 1993.

She was appointed as an assistant professor at the University of Dortmund and as a full professor at the University of Munich. She also held positions as a visiting lecturer and a visiting professor in Mainz, Zurich (Switzerland), Aalborg (Denmark), and Bern (Switzerland). In September 2001 she accepted a full professorship for “Statistics with a Focus on Biometry and Methods in Epidemiology” at the University of Bremen.

The research activities of Prof. Dr. Iris Pigeot focus on use of secondary data in the research of pharmaceutical drug safety as well as primary prevention and its evaluation, especially of childhood obesity, graphical models, and genetic epidemiology. In recent years, she has widened the spectrum of her research to include digital public health as well as statistical and privacy issues related to research data infrastructure.

She received several teaching awards: the “Medal for Excellent Teaching” from the University of Dortmund in 1994, the “Award for Quality Teaching” from the Friends of the University of Munich in 1996, and the “Berninghausen Award for Excellent Teaching and ist Innovation” by the Friends of the University of Bremen and Jacobs University Bremen (so-called unifreunde) in 2008. She was awarded the "Award for Outstanding Doctoral Supervision" for her professional and encouraging support of doctoral candidates in 2019. In 2010, the IBS-DR awarded her the Susanne-Dahms medal for special accomplishments in the field of biometry. The University of Rzeszów, Poland, awarded her together with Wolfgang Ahrens the University's Great Medal in 2020 for her services to the scientific and didactic development of the employees of the Medical Faculty.

She serves among others as a member of the executive board of the International Biometric Society, as a member of the supervisory board of the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures, as a member of the scientific advisory board of ZB MED - Information Centre for Life Sciences, as a member of the advisory board of the Federal Health Journal (Bundesgesundheitsblatt), as a member of the scientific council of the research data centres of the Federal Statistical Office and the statistical offices of the federal states and as an editor of the book series on Epidemiology and Public Health published by Springer.

Research interests

  • Biometrical methods
  • Graphical models
  • Genetic epidemiology
  • Primary prevention and its evaluation, especially of childhood obesity
  • Use of secondary data in research of pharmaceutical drug safety
  • Digital public health
  • Statistical and privacy issues related to research data infrastructure

Memberships

Projects

Selected publications

  • Articles with peer-review

  • Fluck J, Lindstädt B, Ahrens W, Beyan O, Buchner B, Darms J, Depping R, Dierkes J, Neuhausen H, Müller W, Zeeb H, Golebiewski M, Löffler M, Löbe M, Meineke F, Klammt S, Fröhlich H, Hahn H, Schulze M, Pischon T, Nöthlings U, Sax U, Kusch H, Grabenhenrich L, Schmidt CO, Waltemath D, Semler S, Gehrke J, Kirsten T, Prasser F, Thun S, Weiler L, Pigeot I. NFDI4Health - Nationale Forschungsdateninfrastruktur für personenbezogene Gesundheitsdaten. Bausteine Forschungsdatenmanagement: Empfehlungen und Erfahrungsberichte für die Praxis von Forschungsdatenmanagerinnen und -managern. 2021;2:72-85.
    https://doi.org/10.17192/bfdm.2021.2.8331
  • Hörner T, Glöckner FO, Drechsler R, Pigeot I, on behalf of the U Bremen Research Alliance. Disziplinübergreifendes Modell zur Ausbildung von Forschungsdatenmanagement und Data Science Kompetenzen: "Data Train - Training in Research Data Management and Data Science". Bausteine Forschungsdatenmanagement: Empfehlungen und Erfahrungsberichte für die Praxis von Forschungsdatenmanagerinnen und -managern. 2021; (im Druck).
  • Hüls A, Wright MN, Bogl L-H, Kaprio J, Lissner L, Molnár D, Moreno LA, De Henauw S, Siani A, Veidebaum T, Ahrens W, Pigeot I, Foraita R. Polygenic risk for obesity and its interaction with lifestyle and sociodemographic factors in European children and adolescents. International Journal of Obesity. 2021;45(6):1321-1330.
    https://dx.doi.org/10.1038/s41366-021-00795-5
  • Mehlig K, Holmberg C, Bogl L-H, Erhardt E, Hadjigeorgiou C, Hebestreit A, Kaprio J, Lauria F, Michels N, Pigeot I, Reisch LA, Veidebaum T, Lissner L, on behalf of the IDEFICS and I.Family consortia. Weight status and BMI-related traits in adolescent friendship groups and role of sociodemographic factors - The European IDEFICS/I.Family cohort. Obesity Facts. 2021;14(1):121-130.
    https://doi.org/10.1159/000512356
  • NCD Risk Factor Collaboration (NCD-RisC), in collaboration with Ahrens W, Pigeot I, Pohlabeln H. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. eLife. 2021;10:e60060.
    https://doi.org/10.7554/eLife.60060
  • NCD Risk Factor Collaboration (NCD-RisC), in collaboration with Ahrens W, Pigeot I. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1,173 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957-980.
    https://doi.org/10.1016/S0140-6736(21)01330-1
  • Pigeot I, Kollhorst B, Didelez V. Nutzung von Sekundärdaten für die pharmakoepidemiologische Forschung - machen wir das Beste draus! Das Gesundheitswesen. 2021; (im Druck).
  • Priesemann V, Meyer-Hermann M, Pigeot I, Schöbel A. Der Beitrag von epidemiologischen Modellen zur Beschreibung des Ausbruchsgeschehens der COVID-19-Pandemie. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2021;64(9):1058-1066.
    https://doi.org/10.1007/s00103-021-03390-1
  • Schmidt CO, Fluck J, Golebiewski M, Grabenhenrich L, Hahn H, Kirsten T, Klammt S, Löbe M, Sax U, Thun S, Pigeot I, on behalf of the NFDI4Health Task Force COVID-19. COVID-19-Forschungsdaten leichter zugänglich machen – Aufbau einer bundesweiten Informationsinfrastruktur. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2021;64(9):1084-1092.
    https://doi.org/10.1007/s00103-021-03386-x
  • Zeeb H, Ahrens W, Haug U, Grabenhenrich L, Pigeot I. Epidemiologische Ansätze zur Klärung wichtiger Forschungsfragen zu COVID-19 - eine Übersicht. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2021;64(9):1076-1083.
    https://doi.org/10.1007/s00103-021-03378-x
  • Ahrens W, Greiser KH, Linseisen J, Pischon T, Pigeot I. Erforschung von Erkrankungen in der NAKO Gesundheitsstudie. Die wichtigsten gesundheitlichen Endpunkte und ihre Erfassung. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2020;63(4):376-384.
    https://doi.org/10.1007/s00103-020-03111-0
  • Bogl L-H, Mehlig K, Ahrens W, Gwozdz W, De Henauw S, Molnár D, Moreno LA, Pigeot I, Russo P, Solea A, Veidebaum T, Kaprio J, Lissner L, Hebestreit A, on behalf of the IDEFICS and I.Family consortia. Like me, like you – relative importance of peers and siblings on children’s fast food consumption and screen time but not sports club participation depends on age. International Journal of Behavioral Nutrition and Physical Activity. 2020;17:50.
    https://doi.org/10.1186/s12966-020-00953-4
  • Dijkstra L, Garling M, Foraita R, Pigeot I. Adverse drug reaction or innocent bystander? A systematic comparison of statistical discovery methods for spontaneous reporting systems. Pharmacoepidemiology and Drug Safety. 2020;29(4):396-403.
    https://doi.org/10.1002/pds.4970
  • Intemann T, Mehlig K, De Henauw S, Siani A, Constantinou T, Moreno LA, Molnár D, Veidebaum T, Pigeot I, on behalf of the I.Family consortium. SIMEX for correction of dietary exposure effects with Box-Cox transformed data. Biometrical Journal. 2020;62(1):221-237.
    https://doi.org/10.1002/bimj.201900066
  • Linden M, Mohr SB, Dehning J, Mohring J, Meyer-Hermann M, Pigeot I, Schöbel A, Priesemann V. Case numbers beyond contact tracing capacity are endangering the containment of COVID-19. Deutsches Ärzteblatt International. 2020;117(46):790-791.
    https://doi.org/10.3238/arztebl.2020.0790
  • NCD Risk Factor Collaboration (NCD-RisC), in collaboration with Pigeot I, Ahrens W. National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: A pooled analysis of 458 population-based studies in Asian and Western countries. International Journal of Epidemiology. 2020;49(1):173-192.
    https://doi.org/10.1093/ije/dyz099
  • NCD Risk Factor Collaboration (NCD-RisC), in collaboration with Ahrens W, Pigeot I, Pohlabeln H. Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: A pooled analysis of 2181 population-based studies with 65 million participants. The Lancet. 2020;396(10261):1511-1524.
    https://doi.org/10.1016/S0140-6736(20)31859-6
  • NCD Risk Factor Collaboration (NCD-RisC), in collaboration with Ahrens W, Pigeot I, Pohlabeln H. Repositioning of the global epicentre of non-optimal cholesterol. Nature. 2020;582(2):73-77.
    https://doi.org/10.1038/s41586-020-2338-1
  • Rauch G, Hafermann L, Mansmann U, Pigeot I. Comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocols. BMJ Open. 2020;10:e032864.
    https://doi.org/10.1136/bmjopen-2019-032864
  • Schipf S, Schöne G, Schmidt B, Günther K, Stübs G, Greiser KH, Bamberg F, Meinke-Franze C, Becher H, Berger K, Brenner H, Castell S, Damms-Machado A, Fischer B, Franzke C-W, Fricke J, Gastell S, Günther M, Hoffmann W, Holleczek B, Jaeschke L, Jagodzinski A, Jöckel K-H, Kaaks R, Kauczor H-U, Kemmling Y, Kluttig A, Krist L, Kurth B-M, Kuß O, Legath N, Leitzmann M, Lieb W, Linseisen J, Löffler M, Michels K, Mikolajczyk R, Pigeot I, Mueller U, Peters A, Rach S, Schikowski T, Schulze MB, Stallmann C, Stang A, Swart E, Waniek S, Wirkner K, Völzke H, Pischon T, Ahrens W. Die Basiserhebung der NAKO Gesundheitsstudie: Teilnahme an den Untersuchungsmodulen, Qualitätssicherung und Nutzung von Sekundärdaten. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2020;63(3):254-266.
    https://doi.org/10.1007/s00103-020-03093-z
  • Wolters M, Dejanovic GM, Asllanaj E, Günther K, Pohlabeln H, Bramer W, Ahrens J, Nagrani R, Pigeot I, Franco OH, Ahrens W, Muka T, Glisic M. Effects of phytoestrogen supplementation on intermediate cardiovascular disease risk factors among postmenopausal women: A meta-analysis of randomized controlled trials. Menopause. 2020;27(9):1081-1092.
    http://doi.org/10.1097/GME.0000000000001566
  • Zeeb H, Pigeot I, Schüz B. Digital Public Health - Ein Überblick. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2020;63(2):137-144.
    https://doi.org/10.1007/s00103-019-03078-7
  • Articles without peer-review

  • Ciesek S, Nassehi A, Priesemann V, Pigeot I, Prainsack B, Czypionka T, Schöbel A. Eine Perspektive ohne Auf und Ab. Die Zeit. 2021;8:33.
    https://www.zeit.de/2021/08/corona-strategie-lockdown-stufenplan-wissenschaftler-lockerungen
  • Schönfeld DH, Pigeot I, Scholz-Reiter B, on behalf of the U Bremen Research Alliance. Wie man eine Allianz baut. Wissenschaftsmanagement. 2021;1:1-6.
  • Position Papers

  • Meyer-Hermann M, Pigeot I, Priesemann V, Schöbel A. Adaptive Strategien zur Eindämmung der COVID-19-Epidemie. 2020;
    https://www.mpg.de/14760567/28-04-2020_Stellungnahme_Teil_02.pdf
  • Nationale Akademie der Wissenschaften Leopoldina, in collaboration with Pigeot I. Coronavirus-Pandemie: Die Feiertage und den Jahreswechsel für einen harten Lockdown nutzen. Halle (Saale) 2020;
    https://tinyurl.com/y4om5us7
  • Präsidentin der Deutschen Forschungsgemeinschaft, Präsident der Fraunhofer-Gesellschaft, Präsident der Helmholtz-Gemeinschaft, Präsident der Leibniz-Gemeinschaft, Präsident der Max-Planck-Gesellschaft, Präsident der Nationalen Akademie der Wissenschaften Leopoldina, in collaboration with Pigeot I. Coronavirus-Pandemie: Es ist ernst. 2020;
    https://tinyurl.com/yygj4zvf
  • Editorships

  • Pigeot I, Gleich S, Grabenhenrich L. COVID-19 und Public Health: Epidemiologie. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 64(9). Berlin: Springer. 2021.
  • Zeeb H, Pigeot I, Schüz B. Digital Public Health. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 63(2). Berlin: Springer. 2020.
  • Ahrens W, Pigeot I, Pischon T. Die Basiserhebung der NAKO Gesundheitsstudie – Teil I: Erste Ergebnisse zu sozialen und medizinischen Faktoren. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 63(3). Berlin: Springer. 2020.
  • Ahrens W, Pigeot I. Die Basiserhebung der NAKO Gesundheitsstudie – Teil II: Erste Ergebnisse zu häufigen Volkskrankheiten. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 63(4). Berlin: Springer. 2020.
  • Books

  • Bammann K, Lissner L, Pigeot I, Ahrens W, editors. Instruments for health surveys in children and adolescents. Cham: Springer International Publishing; 2019.
  • Fahrmeir L, Heumann C, Künstler R, Pigeot I, Tutz G. Statistik: Der Weg zur Datenanalyse. 8. Auflage. Heidelberg: Springer; 2016.
  • Ahrens W, Pigeot I, editors. Handbook of epidemiology. 2nd edition. New York: Springer; 2014.
  • Kreienbrock L, Pigeot I, Ahrens W. Epidemiologische Methoden. 5. Auflage. Berlin: Springer; 2012.
    https://doi.org/10.1007/978-3-8274-2334-4.
  • Moreno LA, Pigeot I, Ahrens W, editors. Epidemiology of obesity in children and adolescents - Prevalence and etiology. New York: Springer; 2011.
  • Caputo A, Fahrmeir L, Künstler R, Lang S, Pigeot I, Tutz G. Arbeitsbuch Statistik. 5. verbesserte Auflage. Berlin, Heidelberg: Springer; 2008.
  • Hauschke D, Steinijans V, Pigeot I. Bioequivalence studies in drug development - Methods and applications. Chichester: John Wiley & Sons; 2007.
  • Contributions to books and proceedings

  • Pigeot I, Tahden M, Zampatis D, Watson DJ, Forssen U, Kollhorst B. Worldwide availability of pharmacoepidemiological databases. In: Sturkenboom MCJM, Schink T, editors. Databases for pharmacoepidemiological research. Cham: Springer. 2021. S. 15-53.
    https://doi.org/10.1007/978-3-030-51455-6_2
  • Schmidt CO, Darms J, Shutsko A, Löbe M, Nagrani R, Seifert B, Lindstädt B, Golebiewski M, Koleva S, Bender T, Bauer CR, Sax U, Hu X, Lieser M, Junker V, Klopfenstein S, Zeleke A, Waltemath D, Pigeot I, Fluck J, on behalf of the NFDI4Health Task Force COVID-19. Facilitating study and item level browsing for clinical and epidemiological COVID-19 studies. In: Mantas J, Stoicu-Tivadar L, Chronaki C, Hasman A, Weber P, Gallos P, Crisan-Vida M, Zoulias E, Chirila OS, editors. Public Health and Informatics. Amsterdam: IOS Press. 2021. S. 794-798.
    https://doi.org/10.3233/SHTI210284
  • Presentations at scientific meetings/conferences (invited)

  • Pigeot I. Sharing of sensitive health data - Two practical examples. G20 Data Gaps Initiative (DGI) Workshop on Recommendation II.20 "Promotion of Data Sharing," 25 March 2021, online presentation.
  • Pigeot I, Intemann T. Spot urine biomarkers and 24-hour dietary recalls: Validation and measurement error correction. "Diet and Activity Assessment: A Global Vision," International Conference on Diet and Activity Methods (ICDAM), 8-12 February 2021, online presentation.
  • Pigeot I. Data Sharing: Best Practice oder Mission Impossible? Institutskolloquium des Instituts für Medizinische Biometrie, Epidemiologie und Informatik (IMBEI) der Universität Mainz, 16. Januar 2020, Mainz.
  • Pigeot I. Aufbau einer nationalen Forschungsdateninfrastruktur im Bereich Gesundheit mit Fokus auf COVID-19. Pfizer-Input-Vortragsreihe, 7. Oktober 2020, Online-Vortrag.
  • Pigeot I. Prävention und Risikowahrnehmung. Pfizer-Input-Vortragsreihe, 19. November 2020, Online-Vortrag.
  • Pigeot I. Data Science und Data Sharing: Mission Impossible ohne intelligentes Forschungsdatenmanagement? Plenary der Landesinitiative Hessische Forschungsdateninfrastruktur (HeFDI), 17. Dezember 2020, Online-Vortrag.

For further publications please follow this link:

Prizes and awards

  • Große Medaille der Universität Rzeszów
    University of Rzeszów (2020)
    Services to the scientific and didactic development of the employees of the Medical Faculty
  • Preis für herausragende Promotionsbetreuung
    University of Bremen (2019)
    Award for Outstanding Doctoral Supervision
  • 1st Prize in Oral Communication Modality in the Area of Metabolism (W Ahrens, C Börnhorst, I Pigeot)
    European Childhood Obesity Group (ECOG) (2018)
    Oral presentation "Trajectories of overweight and metabolic syndrome in the IDEFICS/I.Family cohort"
  • Nominiert für den L’Oréal-UNESCO Awards For Women in Science
    Leibniz Association (2015)
    Outstanding contribution to the general advancement of science
  • Nominiert für AcademiaNet
    Leibniz Association (2015)
  • Susanne-Dahms-Medaille
    German Region of the International Biometric Society (IBS-DR) (2010)
    for special accomplishments in the field of biometry
  • Berninghausen-Preis für ausgezeichnete Lehre

Teaching

Study course Mathematics (B.Sc., M.Sc.)

  • Estimation and testing
  • Advanced lectures on nonparametric statistics, multiple testing, multivariate statistics or graphical models

Study course Medical Biometry/Biostatistics (M.Sc.)
  • Lectures on statistical modeling (e.g. regression analysis)
  • Seminar on epidemiology

The responsibility for the content of this page lies with Iris Pigeot.